Neuregulin-1 high-producer genotype is associated with a decreased risk of admission to the neonatal intensive care unit

Early Human Development

Volumn 86, Issue 5, 2010, Pages 299-304

  Pleickhardt, Elizabeth P ^a   Celandine, Andrew ^a   Davis, Jonathan M ^a   Chen, Minghua ^a   Schürmann, Peter ^b   Dörk, Thilo ^b   Dammann, Christiane E L ^a,b   Dammann, Olaf ^a,b,c  

^a TUFTS MEDICAL CENTER   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; NEU DIFFERENTIATION FACTOR; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; NRG1 PROTEIN, HUMAN;

ALLELE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE LOCUS; GENETIC SCREENING; GENOTYPE; GESTATIONAL AGE; HETEROZYGOTE; HOMOZYGOSITY; HOSPITAL ADMISSION; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; INFANT; MALE; MULTIPLEX SANDWICH IMMUNOASSAY; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; PROTEIN BLOOD LEVEL; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UMBILICAL CORD BLOOD; BLOOD; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; INFANT, NEWBORN, DISEASES; METABOLISM; PROBABILITY; RISK; STATISTICS AND NUMERICAL DATA; UPREGULATION;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOSPITALIZATION; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INFANT, PREMATURE; INTENSIVE CARE UNITS, NEONATAL; INTERLEUKIN-10; INTERLEUKIN-6; MALE; NEUREGULIN-1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROBABILITY; RISK; UP-REGULATION;

EID: 77954027473     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2010.03.010     Document Type: Article

References (26)

1. Dammann O., Leviton A. Inflammatory brain damage in preterm newborns - dry numbers, wet lab, and causal inference. Early Hum Dev 2004, 79:1-15.
2. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res 1997, 42:1-8.
3. Dammann O., Leviton A. Brain damage in preterm newborns: might enhancement of developmentally-regulated endogenous protection open a door for prevention?. Pediatrics 1999, 104:541-550.
4. Dammann O., Leviton A. Brain damage in preterm newborns: biologic response modification as a strategy to reduce disabilities. J Pediatr 2000, 136:433-438.
5. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003, 284:14-30.
6. Britsch S. The neuregulin-1/ErbB signaling system in development and disease. Adv Anat Embryo Cell Biol 2007, 190:1-65.
7. Dawei L., Collier D.A., Hi L. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Dev 2006, 15:1995-2002.
8. Revillion F., Lhotellier V., Hornez L., Bonneterre J., Peyrat J.P. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features, and prognosis. Ann Onc 2008, 19:73-80.
9. Dammann O., Bueter W., Leviton A., Gressens P., Dammann C.E. Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage. Neonatology 2007, 43:1-6.
10. Dammann C.E., Nielsen H.C., Carraway K.L. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med 2003, 167:1711-1716.
11. Bueter W., Dammann O., Zscheppang K., Korenbaum E., Dammann C.E. ErbB receptors in fetal endothelium - a potential linkage point for inflammation-associated neonatal disorders. Cytokine 2006, 36:267-275.
12. Xu Z., Ford G.D., Croslan D.R., Jiang J., Gates A., Allen R., et al. Neuroprotection by neuregulin-1 following focal stroke is associated with the attenuation of ischemia-induced pro-inflammatory and stress gene expression. Neurobiol Dis 2005, 19:461-470.
13. Lok J., Wang H., Murata Y., Zhu H.H., Qin T., Whalen M.J., et al. Effect of neuregulin-1 on histopathological and functional outcome after controlled cortical impact in mice. J Neurotrauma 2007, 24:1817-1822.
14. Hoffmann I., Bueter W., Zscheppang K., Brinkhaus M.J., Liese A., Riemke S., et al. Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns. Brain Behav Immun 2010, 24:784-791.
15. Ferber A., Minior V.K., Bornstein E., Divon M.Y. Fetal "nonreassuring status" is associated with elevation of nucleated red blood cell counts and interleukin-6. Am J Obstet Gynecol 2005, 192:1427-1429.
16. Kassal R., Anwar M., Kashlan F., Smulian J., Hiatt M., Hegyi T. Umbilical vein interleukin-6 levels in very low birth weight infants developing intraventricular hemorrhage. Brain Dev 2005, 27:483-487.
17. Yoon B.H., Romero R., Yang S.H., Jun J.K., Kim I.O., Choi J.H., et al. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol 1996, 174:1433-1440.
18. Harding D., Brull D., Humphries S.E., Whitelaw A., Montgomery H., Marlow N. Variation in the interleukin-6 gene is associated with impaired cognitive development in children born prematurely: a preliminary study. Pediatr Res 2005, 58:117-120.
19. Dordelmann M., Kerk J., Dressler F., Brinkhaus M.J., Bartels D.B., Dammann C.E., et al. Interleukin-10 high producer allele and ultrasound-defined periventricular white matter abnormalities in preterm infants: a preliminary study. Neuropediatrics 2006, 37:130-136.
20. Kwong K.Y., Jones C.A., Cayabyab R., Lecart C., Khuu N., Rhandhawa I., et al. The effects of IL-10 on proinflammatory cytokine expression (IL-1beta and IL-8) in hyaline membrane disease (HMD). Clin Immunol Immunopathol 1998, 88:105-113.
21. Mesples B., Plaisant F., Gressens P. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 2003, 141:25-32.
22. Rodts-Palenik S., Wyatt-Ashmead J., Pang Y., Thigpen B., Cai Z., Rhodes P., et al. Maternal infection-induced white matter injury is reduced by treatment with interleukin-10. Am J Obstet Gynecol 2004, 191:1387-1392.
23. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001, 21:1458-1463.
24. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997, 24:1-8.
25. Rad R., Dossumbekova A., Neu B., Lang R., Bauer S., Saur D., et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004, 53:1082-1089.
26. Janeway C., et al. Innate immunity. Immunobiology 2001, 35-93. Garland Publishing, New York.